All news

Under a trading plan, Stoke Therapeutics (STOK) medical chief sells 1,051 shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Stoke Therapeutics' Chief Medical Officer, Barry Ticho, sold 1,051 shares of common stock on October 1, 2026, at a weighted-average price of $26.1594 per share. This transaction was conducted under a Rule 10b5-1 trading plan adopted in November 2025. After the sale, Ticho directly held 19,059 shares.

Read original source

STOK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.